Literature DB >> 2108727

Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis.

C Tape1, R Kisilevsky.   

Abstract

The half-lives of two apolipoproteins of mouse high-density lipoproteins, apo A-I and apo SAA, were determined in normal animals and compared with those having an inflammatory condition, or inflammation leading to AA amyloid deposition. The apo A-I half-life was considerably shorter in animals with inflammation and in those that were preamyloidotic, than in controls (t1/2 of 3-3.5 h vs. 10-12 h). The average loss of apo A-I in controls over the first 10 h was 31.1 micrograms/ml per h, while that in inflamed animals was 58.7 micrograms/ml per h a 2-fold increase in apo A-I clearance. The apo SAA half-life was similar in all groups of animals and was of the order of 1.5 h. The concentration of apo SAA during inflammation is however considerably higher (500-1000-fold) than in controls, which implies a much greater clearance rate during inflammation and involving a process which is apparently not saturable. In addition to hypertriglyceridemia and Tangier's disease, ordinary acute inflammation can now be added to those pathological conditions which lead to a significant decrease in apo A-I half-life.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108727     DOI: 10.1016/0005-2760(90)90030-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

2.  Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

Authors:  B M Schreiber; M Veverbrants; R E Fine; J K Blusztajn; M Salmona; A Patel; J D Sipe
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

Review 3.  Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Sarah Förster; Jessica L Harris; Rukhsana Sultana; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

4.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

5.  Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Authors:  Ailing Ji; Xuebing Wang; Victoria P Noffsinger; Drew Jennings; Maria C de Beer; Frederick C de Beer; Lisa R Tannock; Nancy R Webb
Journal:  J Lipid Res       Date:  2020-01-08       Impact factor: 5.922

6.  Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.

Authors:  B Kluve-Beckerman; T Yamada; J Hardwick; J J Liepnieks; M D Benson
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

7.  Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.

Authors:  Xavier Rousset; Boris Vaisman; Bruce Auerbach; Brian R Krause; Reyn Homan; John Stonik; Gyorgy Csako; Robert Shamburek; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

8.  Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

Authors:  Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle
Journal:  J Diabetes Complications       Date:  2016-07-27       Impact factor: 2.852

9.  Evaluation of an in-clinic Serum Amyloid A (SAA) assay and assessment of the effects of storage on SAA samples.

Authors:  Anna Hillström; Harold Tvedten; Inger Lilliehöök
Journal:  Acta Vet Scand       Date:  2010-02-02       Impact factor: 1.695

10.  Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Authors:  Jeffrey J Bazarian; Brian J Blyth; Hua He; Sohug Mookerjee; Courtney Jones; Karin Kiechle; Ryan Moynihan; Susan M Wojcik; William D Grant; LaLainia M Secreti; Wayne Triner; Ronald Moscati; August Leinhart; George L Ellis; Jawwad Khan
Journal:  J Neurotrauma       Date:  2013-08-24       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.